- See Also
- Gwern
-
Links
- “AlphaFold2 Structures Template Ligand Discovery”, Lyu et al 2023
- “Elon Musk’s Shadow Rule: How the U.S. Government Came to Rely on the Tech Billionaire—And Is Now Struggling to Rein Him in § Biography”, Farrow 2023
- “In Vivo Biosynthesis of N,N-Dimethyltryptamine, 5-MeO-N,N-Dimethyltryptamine, and Bufotenine in E. Coli”, Friedberg et al 2023
- “Magic Mushrooms. LSD. Ketamine. The Drugs That Power Silicon Valley”, Grind & Bindley 2023
- “Randomized Trial of Ketamine Masked by Surgical Anesthesia in Depressed Patients”, Lii et al 2023
- “Ketamine versus ECT for Non-Psychotic Treatment-Resistant Major Depression”, Anand et al 2023
- “The Evolution and Ecology of Psilocybin in Nature”, Meyer & Slot 2023c
- “Effect of Psilocybin on Marble Burying in ICR Mice: Role of 5-HT1A Receptors and Implications for the Treatment of Obsessive-Compulsive Disorder”, Singh et al 2023
- “Homo Medicus: The Transition to Meat Eating Increased Pathogen Pressure and the Use of Pharmacological Plants in Homo”, Hagen et al 2023
- “Pharmacological Mechanism of the Non-Hallucinogenic 5-HT2A Agonist Ariadne and Analogs”, Cunningham et al 2023
- “Single-Dose Psilocybin-Assisted Therapy in Major Depressive Disorder: A Placebo-Controlled, Double-Blind, Randomized Clinical Trial”, Rotz et al 2022
- “A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability”, Barber et al 2022
- “Acid Liberalism: Silicon Valley’s Enlightened Technocrats, and the Legalization of Psychedelics”, Tvorun-Dunn 2022
- “Adverse Effects of Ayahuasca: Results from the Global Ayahuasca Survey”, Bouso et al 2022
- “5-MeO-DMT Modifies Innate Behaviors and Promotes Structural Neural Plasticity in Mice”, Jefferson et al 2022
- “Low Doses of Lysergic Acid Diethylamide (LSD) Increase Reward-Related Brain Activity”, Glazer et al 2022
- “Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial”, Bogenschutz et al 2022
- “Psilocybin and the Meaning Response: Exploring the Healing Process in a Retreat Setting in Jamaica”, Orozco & Harris 2022
- “Increased Global Integration in the Brain After Psilocybin Therapy for Depression”, Daws et al 2022
- “Trips and Neurotransmitters: Discovering Principled Patterns across 6,850 Hallucinogenic Experiences”, Ballentine et al 2022
- “The Insights Psychedelics Give You Aren’t Always True: The Study of False—Sober—Insights Teaches Us to Be Wary of Accepting Every Realization from Psychedelic Trips without Critical Thinking”, Love 2022
- “Efficacy and Safety of Psilocybin-Assisted Treatment for Major Depressive Disorder: Prospective 12-Month Follow-Up”, Gukasyan et al 2022
- “Digital Localization in an Illicit Market Space: Interactional Creation of a Psychedelic Assemblage in a Darknet Community of Exchange”, Sawicka et al 2022
- “Evenings With Molly: Adult Couples’ Use of MDMA for Relationship Enhancement”, Colbert & Hughes 2022
- “The Effects of Psilocybin on Cognitive and Emotional Functions in Healthy Participants: Results from a Phase 1, Randomized, Placebo-Controlled Trial Involving Simultaneous Psilocybin Administration and Preparation”, Rucker et al 2022
- “United States National Institutes of Health Grant Funding for Psychedelic-Assisted Therapy Clinical Trials from 2006–2020”, Barnett et al 2022
- “Brain Changes Associated With Long-Term Ketamine Abuse, A Systematic Review”, Strous et al 2022
- “Debunking the Myth of ‘Blue Mondays’: No Evidence of Affect Drop After Taking Clinical MDMA”, Sessa et al 2021
- “Microevidence for Microdosing With Psilocybin Mushrooms: a Double-Blind Placebo-Controlled Study of Subjective Effects, Behavior, Creativity, Perception, Cognition, and Brain Activity”, Cavanna et al 2021
- “Psychedelics Alter Metaphysical Beliefs”, Timmermann et al 2021
- “Adults Who Microdose Psychedelics Report Health Related Motivations and Lower Levels of Anxiety and Depression Compared to Non-Microdosers”, Rootman et al 2021
- “Largest Psilocybin Trial Finds the Psychedelic Is Effective in Treating Serious Depression”, Goldhill 2021
- “Psilocybin Therapy Increases Cognitive and Neural Flexibility in Patients With Major Depressive Disorder”, Doss et al 2021
- “Wastewater Analysis for Psychoactive Substances at Music Festivals across New South Wales, Australia in 2019–2020”, Jonathan et al 2021
- “Psilocybin Induces Rapid and Persistent Growth of Dendritic Spines in Frontal Cortex in Vivo”, Shao et al 2021
- “Leroy’s Elusive Little People: A Systematic Review on Lilliputian Hallucinations”, Blom 2021
- “What Happens When You Ask Questions to the DMT Entities?”, Josikinz & algekalipso 2021
- “Psychedelic-Inspired Drug Discovery Using an Engineered Biosensor”, Dong et al 2021
- “MDMA-Assisted Therapy for Severe PTSD: a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study”, Mitchell et al 2021
- “A ’Trip’ to the Intensive Care Unit: An Intravenous Injection of Psilocybin”, Giancola et al 2021
- “The Psychology of Philosophy: Associating Philosophical Views With Psychological Traits in Professional Philosophers”, Yaden & Anderson 2021
- “Trial of Psilocybin versus Escitalopram for Depression”, Carhart-Harris et al 2021
- “Self-Blinding Citizen Science to Explore Psychedelic Microdosing”, Szigeti et al 2021
- “Citizen Science: Asking Questions of Psychedelic Microdosing”, Cameron 2021
- “The Acute Antisuicidal Effects of Single-Dose Intravenous Ketamine and Intranasal Esketamine in Individuals With Major Depression and Bipolar Disorders: A Systematic Review and Meta-Analysis”, Xiong et al 2021
- “Positive Expectations Predict Improved Mental-Health Outcomes Linked to Psychedelic Microdosing”, Kaertner et al 2021
- “Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial”, Davis et al 2021
- “A Non-Hallucinogenic Psychedelic Analogue With Therapeutic Potential”, Cameron et al 2021
- “Psychedelic Drugs: Neurobiology and Potential for Treatment of Psychiatric Disorders”, Vollenweider & Preller 2020
- “Obscure and Unknown: Deliriants of the Edgewood Arsenal Human Experiments”, space_crustacean 2020
- “Survey of Entity Encounter Experiences Occasioned by Inhaled N,N-Dimethyltryptamine: Phenomenology, Interpretation, and Enduring Effects”, Davis et al 2020
- “Psychedelic Psychiatry’s Brave New World”, Nutt et al 2020
- “Long-Term Follow-Up of Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Patients With Life-Threatening Cancer”, Agin-Liebes et al 2020
- “What Intellectual Progress Did I Make In The 2010s?”, Alexander 2020
- “Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Low Dose Lysergic Acid Diethylamide (LSD) in Healthy Older Volunteers”, Family et al 2020
- “Metabolic Engineering of Saccharomyces Cerevisiae for the de Novo Production of Psilocybin and Related Tryptamine Derivatives”, Milne et al 2020
- “Logarithmic Scales of Pleasure and Pain: Rating, Ranking, and Comparing Peak Experiences Suggest the Existence of Long Tails for Bliss and Suffering”, Computing 2019
- “Acute Subjective and Behavioral Effects of Microdoses of Lysergic Acid Diethylamide in Healthy Human Volunteers”, Bershad et al 2019
- “A Systematic Study of Microdosing Psychedelics”, Polito & Stevenson 2018
- “Exploring the Effect of Microdosing Psychedelics on Creativity in an Open-Label Natural Setting”, Prochazkova et al 2018
- “Discovery of Psychoactive Plant and Mushroom Alkaloids in Behavior-Modifying Fungal Cicada Pathogens”, Boyce et al 2018
- “Convergent Evolution of Psilocybin Biosynthesis by Psychedelic Mushrooms”, Awan et al 2018
- “Psychedelics and the Essential Importance of Context”, Carhart-Harris et al 2018
- “Psilocybin With Psychological Support for Treatment-Resistant Depression: Six-Month Follow-Up”, Carhart-Harris et al 2018
- “Serotonin and Brain Function: a Tale of Two Receptors”, Carhart-Harris & Nutt 2017
- “The Challenging Experience Questionnaire: Characterization of Challenging Experiences With Psilocybin Mushrooms”
- “Survey Study of Challenging Experiences After Ingesting Psilocybin Mushrooms: Acute and Enduring Positive and Negative Consequences”
- “NMDAR Inhibition-Independent Antidepressant Actions of Ketamine Metabolites”, Zanos et al 2016
- “Rapid and Sustained Symptom Reduction following Psilocybin Treatment for Anxiety and Depression in Patients With Life-Threatening Cancer: a Randomized Controlled Trial”, Ross et al 2016
- “Hunting and Hallucinogens: The Use of Psychoactive and Other Plants to Improve the Hunting Ability of Dogs”, Bennett & Alarcón 2015
- “Clusters of Individual Experiences Form a Continuum of Persistent Non-Symbolic Experiences [PNSE] in Adults”, Martin 2013
- “A Philosopher Defends Religion [review of Plantinga, Where the Conflict Really Lies]”, Nagel 2012
- “Mystical Experiences Occasioned by the Hallucinogen Psilocybin Lead to Increases in the Personality Domain of Openness”, MacLean et al 2011
- “Hyper-Priming in Cannabis Users: A Naturalistic Study of the Effects of Cannabis on Semantic Memory Function”, Morgan et al 2010
- “A Methodology for Studying Various Interpretations of the N,N-Dimethyltryptamine-Induced Alternate Reality”, Rodriguez 2006
- “The Bayesian Brain: the Role of Uncertainty in Neural Coding and Computation”, Knill & Pouget 2004
- “Ketamine: Dreams and Realities”, Jansen 2004
- “A Multidisciplinary Approach to Ritual Enema Scenes on Ancient Maya Pottery”, Smet & Hellmuth 1986
- “Religious Behavior in Animals and Man: Drug-Induced Effects”, Siegel 1977
- “An Ethologic Search for Self-Administration of Hallucinogens”, Siegel 1973
- “An Essay On The Psychology Of Invention In The Mathematical Field”, Hadamard 1945
- “Psychedelics in American Religious Experience”
- “Volumetric Liquid Dosing”, Wiki 2024
- “Benefits Of Microdosing With LSD And Psilocybin Mushrooms”
- “SSC Journal Club: Serotonin Receptors”
- “Does Psilocybin Cause Changes in Personality? Maybe, but Not so Fast”
- “Abstracts regarding Low Doses of LSD (Less Than 50μg)”
- “The Life-Changing Magic of Mushrooms: A Single Dose of Magic Mushrooms Can Make People With Severe Anxiety and Depression Better for Months, according to a Landmark Pair of New Studies.”
- “Do Drugs Make Religious Experience Possible? They Did for James and for Other Philosopher-Mystics of His Day. James’s Experiments With Psychoactive Drugs Raise Difficult Questions about Belief and Its Conditions”
- Sort By Magic
- Wikipedia
- Miscellaneous
- Link Bibliography
See Also
Gwern
“Spaced Repetition for Efficient Learning”, Gwern 2009
“The Algernon Argument”, Gwern 2010
Links
“AlphaFold2 Structures Template Ligand Discovery”, Lyu et al 2023
“Elon Musk’s Shadow Rule: How the U.S. Government Came to Rely on the Tech Billionaire—And Is Now Struggling to Rein Him in § Biography”, Farrow 2023
“In Vivo Biosynthesis of N,N-Dimethyltryptamine, 5-MeO-N,N-Dimethyltryptamine, and Bufotenine in E. Coli”, Friedberg et al 2023
“Magic Mushrooms. LSD. Ketamine. The Drugs That Power Silicon Valley”, Grind & Bindley 2023
Magic Mushrooms. LSD. Ketamine. The Drugs That Power Silicon Valley
“Randomized Trial of Ketamine Masked by Surgical Anesthesia in Depressed Patients”, Lii et al 2023
Randomized Trial of Ketamine Masked by Surgical Anesthesia in Depressed Patients
“Ketamine versus ECT for Non-Psychotic Treatment-Resistant Major Depression”, Anand et al 2023
Ketamine versus ECT for Non-psychotic Treatment-Resistant Major Depression
“The Evolution and Ecology of Psilocybin in Nature”, Meyer & Slot 2023c
“Effect of Psilocybin on Marble Burying in ICR Mice: Role of 5-HT1A Receptors and Implications for the Treatment of Obsessive-Compulsive Disorder”, Singh et al 2023
“Homo Medicus: The Transition to Meat Eating Increased Pathogen Pressure and the Use of Pharmacological Plants in Homo”, Hagen et al 2023
“Pharmacological Mechanism of the Non-Hallucinogenic 5-HT2A Agonist Ariadne and Analogs”, Cunningham et al 2023
Pharmacological Mechanism of the Non-hallucinogenic 5-HT2A Agonist Ariadne and Analogs
“Single-Dose Psilocybin-Assisted Therapy in Major Depressive Disorder: A Placebo-Controlled, Double-Blind, Randomized Clinical Trial”, Rotz et al 2022
“A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability”, Barber et al 2022
“Acid Liberalism: Silicon Valley’s Enlightened Technocrats, and the Legalization of Psychedelics”, Tvorun-Dunn 2022
Acid liberalism: Silicon Valley’s enlightened technocrats, and the legalization of psychedelics
“Adverse Effects of Ayahuasca: Results from the Global Ayahuasca Survey”, Bouso et al 2022
Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey
“5-MeO-DMT Modifies Innate Behaviors and Promotes Structural Neural Plasticity in Mice”, Jefferson et al 2022
5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice
“Low Doses of Lysergic Acid Diethylamide (LSD) Increase Reward-Related Brain Activity”, Glazer et al 2022
Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity
“Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial”, Bogenschutz et al 2022
“Psilocybin and the Meaning Response: Exploring the Healing Process in a Retreat Setting in Jamaica”, Orozco & Harris 2022
Psilocybin and the Meaning Response: Exploring the Healing Process in a Retreat Setting in Jamaica
“Increased Global Integration in the Brain After Psilocybin Therapy for Depression”, Daws et al 2022
Increased global integration in the brain after psilocybin therapy for depression
“Trips and Neurotransmitters: Discovering Principled Patterns across 6,850 Hallucinogenic Experiences”, Ballentine et al 2022
Trips and neurotransmitters: Discovering principled patterns across 6,850 hallucinogenic experiences
“The Insights Psychedelics Give You Aren’t Always True: The Study of False—Sober—Insights Teaches Us to Be Wary of Accepting Every Realization from Psychedelic Trips without Critical Thinking”, Love 2022
“Efficacy and Safety of Psilocybin-Assisted Treatment for Major Depressive Disorder: Prospective 12-Month Follow-Up”, Gukasyan et al 2022
“Digital Localization in an Illicit Market Space: Interactional Creation of a Psychedelic Assemblage in a Darknet Community of Exchange”, Sawicka et al 2022
“Evenings With Molly: Adult Couples’ Use of MDMA for Relationship Enhancement”, Colbert & Hughes 2022
Evenings with Molly: Adult Couples’ Use of MDMA for Relationship Enhancement
“The Effects of Psilocybin on Cognitive and Emotional Functions in Healthy Participants: Results from a Phase 1, Randomized, Placebo-Controlled Trial Involving Simultaneous Psilocybin Administration and Preparation”, Rucker et al 2022
“United States National Institutes of Health Grant Funding for Psychedelic-Assisted Therapy Clinical Trials from 2006–2020”, Barnett et al 2022
“Brain Changes Associated With Long-Term Ketamine Abuse, A Systematic Review”, Strous et al 2022
Brain Changes Associated With Long-Term Ketamine Abuse, A Systematic Review
“Debunking the Myth of ‘Blue Mondays’: No Evidence of Affect Drop After Taking Clinical MDMA”, Sessa et al 2021
Debunking the myth of ‘Blue Mondays’: No evidence of affect drop after taking clinical MDMA
“Microevidence for Microdosing With Psilocybin Mushrooms: a Double-Blind Placebo-Controlled Study of Subjective Effects, Behavior, Creativity, Perception, Cognition, and Brain Activity”, Cavanna et al 2021
“Psychedelics Alter Metaphysical Beliefs”, Timmermann et al 2021
“Adults Who Microdose Psychedelics Report Health Related Motivations and Lower Levels of Anxiety and Depression Compared to Non-Microdosers”, Rootman et al 2021
“Largest Psilocybin Trial Finds the Psychedelic Is Effective in Treating Serious Depression”, Goldhill 2021
Largest psilocybin trial finds the psychedelic is effective in treating serious depression
“Psilocybin Therapy Increases Cognitive and Neural Flexibility in Patients With Major Depressive Disorder”, Doss et al 2021
“Wastewater Analysis for Psychoactive Substances at Music Festivals across New South Wales, Australia in 2019–2020”, Jonathan et al 2021
“Psilocybin Induces Rapid and Persistent Growth of Dendritic Spines in Frontal Cortex in Vivo”, Shao et al 2021
Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo
“Leroy’s Elusive Little People: A Systematic Review on Lilliputian Hallucinations”, Blom 2021
Leroy’s elusive little people: A systematic review on lilliputian hallucinations
“What Happens When You Ask Questions to the DMT Entities?”, Josikinz & algekalipso 2021
“Psychedelic-Inspired Drug Discovery Using an Engineered Biosensor”, Dong et al 2021
Psychedelic-inspired drug discovery using an engineered biosensor
“MDMA-Assisted Therapy for Severe PTSD: a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study”, Mitchell et al 2021
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
“A ’Trip’ to the Intensive Care Unit: An Intravenous Injection of Psilocybin”, Giancola et al 2021
A ’Trip’ to the Intensive Care Unit: An Intravenous Injection of Psilocybin
“The Psychology of Philosophy: Associating Philosophical Views With Psychological Traits in Professional Philosophers”, Yaden & Anderson 2021
“Trial of Psilocybin versus Escitalopram for Depression”, Carhart-Harris et al 2021
“Self-Blinding Citizen Science to Explore Psychedelic Microdosing”, Szigeti et al 2021
Self-blinding citizen science to explore psychedelic microdosing
“Citizen Science: Asking Questions of Psychedelic Microdosing”, Cameron 2021
Citizen Science: Asking questions of psychedelic microdosing
“The Acute Antisuicidal Effects of Single-Dose Intravenous Ketamine and Intranasal Esketamine in Individuals With Major Depression and Bipolar Disorders: A Systematic Review and Meta-Analysis”, Xiong et al 2021
“Positive Expectations Predict Improved Mental-Health Outcomes Linked to Psychedelic Microdosing”, Kaertner et al 2021
Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing
“Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial”, Davis et al 2021
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial
“A Non-Hallucinogenic Psychedelic Analogue With Therapeutic Potential”, Cameron et al 2021
A non-hallucinogenic psychedelic analogue with therapeutic potential
“Psychedelic Drugs: Neurobiology and Potential for Treatment of Psychiatric Disorders”, Vollenweider & Preller 2020
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
“Obscure and Unknown: Deliriants of the Edgewood Arsenal Human Experiments”, space_crustacean 2020
Obscure and Unknown: Deliriants of the Edgewood Arsenal Human Experiments
“Survey of Entity Encounter Experiences Occasioned by Inhaled N,N-Dimethyltryptamine: Phenomenology, Interpretation, and Enduring Effects”, Davis et al 2020
“Psychedelic Psychiatry’s Brave New World”, Nutt et al 2020
“Long-Term Follow-Up of Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Patients With Life-Threatening Cancer”, Agin-Liebes et al 2020
“What Intellectual Progress Did I Make In The 2010s?”, Alexander 2020
“Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Low Dose Lysergic Acid Diethylamide (LSD) in Healthy Older Volunteers”, Family et al 2020
“Metabolic Engineering of Saccharomyces Cerevisiae for the de Novo Production of Psilocybin and Related Tryptamine Derivatives”, Milne et al 2020
“Logarithmic Scales of Pleasure and Pain: Rating, Ranking, and Comparing Peak Experiences Suggest the Existence of Long Tails for Bliss and Suffering”, Computing 2019
“Acute Subjective and Behavioral Effects of Microdoses of Lysergic Acid Diethylamide in Healthy Human Volunteers”, Bershad et al 2019
“A Systematic Study of Microdosing Psychedelics”, Polito & Stevenson 2018
“Exploring the Effect of Microdosing Psychedelics on Creativity in an Open-Label Natural Setting”, Prochazkova et al 2018
Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting
“Discovery of Psychoactive Plant and Mushroom Alkaloids in Behavior-Modifying Fungal Cicada Pathogens”, Boyce et al 2018
Discovery of psychoactive plant and mushroom alkaloids in behavior-modifying fungal cicada pathogens
“Convergent Evolution of Psilocybin Biosynthesis by Psychedelic Mushrooms”, Awan et al 2018
Convergent evolution of psilocybin biosynthesis by psychedelic mushrooms
“Psychedelics and the Essential Importance of Context”, Carhart-Harris et al 2018
“Psilocybin With Psychological Support for Treatment-Resistant Depression: Six-Month Follow-Up”, Carhart-Harris et al 2018
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
“Serotonin and Brain Function: a Tale of Two Receptors”, Carhart-Harris & Nutt 2017
“The Challenging Experience Questionnaire: Characterization of Challenging Experiences With Psilocybin Mushrooms”
View PDF:
“Survey Study of Challenging Experiences After Ingesting Psilocybin Mushrooms: Acute and Enduring Positive and Negative Consequences”
“NMDAR Inhibition-Independent Antidepressant Actions of Ketamine Metabolites”, Zanos et al 2016
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
“Rapid and Sustained Symptom Reduction following Psilocybin Treatment for Anxiety and Depression in Patients With Life-Threatening Cancer: a Randomized Controlled Trial”, Ross et al 2016
“Hunting and Hallucinogens: The Use of Psychoactive and Other Plants to Improve the Hunting Ability of Dogs”, Bennett & Alarcón 2015
“Clusters of Individual Experiences Form a Continuum of Persistent Non-Symbolic Experiences [PNSE] in Adults”, Martin 2013
“A Philosopher Defends Religion [review of Plantinga, Where the Conflict Really Lies]”, Nagel 2012
A Philosopher Defends Religion [review of Plantinga, Where the Conflict Really Lies]
“Mystical Experiences Occasioned by the Hallucinogen Psilocybin Lead to Increases in the Personality Domain of Openness”, MacLean et al 2011
“Hyper-Priming in Cannabis Users: A Naturalistic Study of the Effects of Cannabis on Semantic Memory Function”, Morgan et al 2010
“A Methodology for Studying Various Interpretations of the N,N-Dimethyltryptamine-Induced Alternate Reality”, Rodriguez 2006
“The Bayesian Brain: the Role of Uncertainty in Neural Coding and Computation”, Knill & Pouget 2004
The Bayesian brain: the role of uncertainty in neural coding and computation
“Ketamine: Dreams and Realities”, Jansen 2004
“A Multidisciplinary Approach to Ritual Enema Scenes on Ancient Maya Pottery”, Smet & Hellmuth 1986
A multidisciplinary approach to ritual enema scenes on ancient Maya pottery
“Religious Behavior in Animals and Man: Drug-Induced Effects”, Siegel 1977
“An Ethologic Search for Self-Administration of Hallucinogens”, Siegel 1973
An Ethologic Search for Self-Administration of Hallucinogens
“An Essay On The Psychology Of Invention In The Mathematical Field”, Hadamard 1945
An Essay On The Psychology Of Invention In The Mathematical Field
“Psychedelics in American Religious Experience”
“Volumetric Liquid Dosing”, Wiki 2024
“Benefits Of Microdosing With LSD And Psilocybin Mushrooms”
“SSC Journal Club: Serotonin Receptors”
“Does Psilocybin Cause Changes in Personality? Maybe, but Not so Fast”
Does psilocybin cause changes in personality? Maybe, but not so fast
“Abstracts regarding Low Doses of LSD (Less Than 50μg)”
“The Life-Changing Magic of Mushrooms: A Single Dose of Magic Mushrooms Can Make People With Severe Anxiety and Depression Better for Months, according to a Landmark Pair of New Studies.”
“Do Drugs Make Religious Experience Possible? They Did for James and for Other Philosopher-Mystics of His Day. James’s Experiments With Psychoactive Drugs Raise Difficult Questions about Belief and Its Conditions”
Sort By Magic
Annotations sorted by machine learning into inferred 'tags'. This provides an alternative way to browse: instead of by date order, one can browse in topic order. The 'sorted' list has been automatically clustered into multiple sections & auto-labeled for easier browsing.
Beginning with the newest annotation, it uses the embedding of each annotation to attempt to create a list of nearest-neighbor annotations, creating a progression of topics. For more details, see the link.
hallucinogen-study
psilocybin-research
psychedelic-therapy
microdosing-health
Wikipedia
Miscellaneous
-
/doc/psychedelic/2021-timmermann-figure5-psilocybinaltersmetaphysicalbeliefsindepressionpatients.png: -
/doc/psychedelic/1973-siegel-table2-animaldrugselfadministration.png: -
http://www.sciencedirect.com/science/article/pii/S0278584615000603 -
http://www.westword.com/news/denvers-underground-lsd-labs-fueled-the-psychedelic-revolution-9644844: -
https://akjournals.com/view/journals/2054/5/1/article-p1.xml: -
https://en.wikipedia.org/w/index.php?title=LSD_and_schizophrenia&oldid=699494403 -
https://en.wikisource.org/wiki/Subjective_Effects_of_Nitrous_Oxide -
https://icpr2020.net/anonymous-donation-on-reddit-changed-everything-for-mdma-research/: -
https://insanebraintrain.blogspot.com/2011/07/massive-dosing-lsd-thumbprint.html: -
https://journals.sagepub.com/doi/abs/10.1177/0269881119897615 -
https://lareviewofbooks.org/article/psychedelic-pioneer-and-confidence-man/: -
https://medium.com/the-shadow/hot-take-psilocybin-was-the-biggest-mistake-of-my-life-f93cf6598974 -
https://newatlas.com/psilocybin-magic-mushrooms-depression-fda-breakthrough-therapy/56928/: -
https://nymag.com/news/features/synthetic-drugs-2013-4/:View External Link:
-
https://nymag.com/news/features/synthetic-drugs-2013-4/#print:View External Link:
https://nymag.com/news/features/synthetic-drugs-2013-4/#print -
https://petergasser.ch/wp-content/uploads/2019/05/LSD-assisted-psychotherapy-followup-JOP-full.pdf: -
https://przekroj.pl/en/society/a-communist-lsd-trip-aleksander-kaczorowski: -
https://publicdomainreview.org/essay/brilliant-visions-peyote-among-the-aesthetes/ -
https://publicdomainreview.org/essay/fungi-folklore-and-fairyland/ -
https://qualiacomputing.com/2015/06/09/state-space-of-drug-effects-results/ -
https://qualiacomputing.com/2020/03/08/making-amazing-recreational-drug-cocktails/: -
https://qz.com/1454785/a-millionaire-couple-is-threatening-to-create-a-magic-mushroom-monopoly -
https://resobscura.substack.com/p/why-did-it-take-psychedelics-so-long -
https://sashachapin.substack.com/p/5-meo-dmt-a-review-by-a-confused -
https://slatestarcodex.com/2016/04/28/why-were-early-psychedelicists-so-weird/ -
https://slatestarcodex.com/2016/08/11/book-review-pihkal/:View External Link:
-
https://slatestarcodex.com/2019/07/23/book-review-the-electric-kool-aid-acid-test/: -
https://thereader.mitpress.mit.edu/an-untold-story-of-lsd-psychotherapy-in-communist-czechoslovakia/ -
https://web.archive.org/web/20141216013118/http://secretlaboratory.org/?p=9543 -
https://www.amazon.com/The-Psychedelic-Explorers-Guide-Therapeutic/dp/1594774021/ -
https://www.amazon.com/Turings-Cathedral-Origins-Digital-Universe/dp/1400075998/ -
https://www.astralcodexten.com/p/on-cerebralab-on-nuttcarhart-harris -
https://www.discovermagazine.com/mind/the-amazing-psychedelic-bamboozle -
https://www.discovermagazine.com/mind/the-handeloh-happening-psychedelic-poisoning -
https://www.frontiersin.org/articles/10.3389/fpsyg.2018.01028/full -
https://www.mondo2000.com/2018/06/18/the-inspiration-for-hypercard/ -
https://www.newyorker.com/magazine/2015/02/09/trip-treatment -
https://www.newyorker.com/magazine/2015/11/23/the-trip-planners -
https://www.nytimes.com/2010/04/12/science/12psychedelics.html -
https://www.nytimes.com/2012/04/22/magazine/how-psychedelic-drugs-can-help-patients-face-death.html -
https://www.nytimes.com/2017/05/06/style/psychedelic-drug-resurgence-daily-life.html -
https://www.nytimes.com/2019/09/04/science/psychedelic-drugs-hopkins-depression.html -
https://www.nytimes.com/2019/09/06/health/ferriss-psychedelic-drugs-depression.html -
https://www.nytimes.com/2023/02/20/us/ketamine-telemedicine.html -
https://www.nytimes.com/2024/03/21/health/psychedelics-roland-griffiths-johns-hopkins.html -
https://www.sciencedirect.com/science/article/pii/S0028390817306391 -
https://www.sciencedirect.com/science/article/pii/S1053811919302952 -
https://www.tandfonline.com/doi/abs/10.1080/02791072.2016.1234090 -
https://www.the-scientist.com/features/decoding-the-tripping-brain-30240 -
https://www.theatlantic.com/science/archive/2018/07/massospora-parasite-drugs-its-hosts/566324/ -
https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(16)30065-7/abstract -
https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(18)30135-4/abstract: -
https://www.vectorsofmind.com/p/the-snake-cult-of-consciousness -
https://www.vice.com/en/article/4adngq/psychedelic-drug-use-in-ancient-indigenous-cultures -
https://www.vice.com/en/article/m7vxm8/its-time-to-start-studying-the-downside-of-psychedelics -
https://www.vice.com/en/article/xgz3wn/psychedelic-therapy-needs-to-confront-the-mystical -
https://www.wired.com/2017/05/scientists-want-give-money-study-psychedelics/: -
https://www.wired.com/story/hackers-mason-jars-psychedelic-science-diy-shrooms/: -
https://www.wired.com/story/race-to-engineer-new-psychedelic-drugs/:View External Link:
https://www.wired.com/story/race-to-engineer-new-psychedelic-drugs/ -
https://www.wsj.com/articles/the-new-science-of-psychedelics-1525360091:View External Link:
https://www.wsj.com/articles/the-new-science-of-psychedelics-1525360091
Link Bibliography
-
https://www.biorxiv.org/content/10.1101/2023.12.20.572662.full: “AlphaFold2 Structures Template Ligand Discovery”, -
2023-friedberg.pdf: “In Vivo Biosynthesis of N,N-Dimethyltryptamine, 5-MeO-N,N-Dimethyltryptamine, and Bufotenine in E. Coli”, -
https://onlinelibrary.wiley.com/doi/10.1002/ajpa.24718: “Homo Medicus: The Transition to Meat Eating Increased Pathogen Pressure and the Use of Pharmacological Plants in Homo”, Edward H. Hagen, Aaron D. Blackwell, Aaron D. Lightner, Roger J. Sullivan -
2022-orozco.pdf: “Psilocybin and the Meaning Response: Exploring the Healing Process in a Retreat Setting in Jamaica”, Maria Orozco, Shana Harris -
https://www.nature.com/articles/s41591-022-01744-z: “Increased Global Integration in the Brain After Psilocybin Therapy for Depression”, -
https://www.vice.com/en/article/5dgkkn/the-insights-psychedelics-give-you-arent-always-true: “The Insights Psychedelics Give You Aren’t Always True: The Study of False—Sober—Insights Teaches Us to Be Wary of Accepting Every Realization from Psychedelic Trips without Critical Thinking”, Shayla Love -
https://journals.sagepub.com/doi/full/10.1177/02698811211064720: “The Effects of Psilocybin on Cognitive and Emotional Functions in Healthy Participants: Results from a Phase 1, Randomized, Placebo-Controlled Trial Involving Simultaneous Psilocybin Administration and Preparation”, -
https://qualiacomputing.com/2021/05/14/what-happens-when-you-ask-questions-to-the-dmt-entities/: “What Happens When You Ask Questions to the DMT Entities?”, Josikinz, algekalipso -
2021-yaden.pdf: “The Psychology of Philosophy: Associating Philosophical Views With Psychological Traits in Professional Philosophers”, David B. Yaden, Derek E. Anderson -
https://elifesciences.org/articles/66920: “Citizen Science: Asking Questions of Psychedelic Microdosing”, Lindsay P. Cameron -
2007-rodriguez.pdf: “A Methodology for Studying Various Interpretations of the N,N-Dimethyltryptamine-Induced Alternate Reality”, Marko A. Rodriguez -
https://archive.org/details/eassayonthepsych006281mbp: “An Essay On The Psychology Of Invention In The Mathematical Field”, Jacques Hadamard